Results 281 to 290 of about 84,264 (300)

CoMFA of benzyl derivatives of 2,1,3-benzo and benzothieno[3,2-a]thiadiazine 2,2-dioxides: clues for the design of phosphodiesterase 7 inhibitors

European Journal of Medicinal Chemistry, 2001
Ana Castro, Carmen Gil, Ana Martinez
exaly  

Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential

Bioorganic and Medicinal Chemistry, 2016
Nariman F Salakhutdinov, Olga Lavrik
exaly  

Phosphodiesterase Inhibitors

2012
openaire   +1 more source

Phosphodiesterase‐5 Inhibitors and Migraine

Headache: The Journal of Head and Face Pain, 2004
Evans, Randolph W, Kruuse, Christina Rostrup   +1 more
openaire   +3 more sources

Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors

Expert Opinion on Drug Metabolism and Toxicology, 2017
Isaac Y Kim
exaly  

The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice

Journal of Psychopharmacology, 2012
Shervin Liddie
exaly  

Phosphodiesterases and Their Inhibitors

2014
openaire   +1 more source

The Relationship between Erectile Dysfunction and Lower Urinary Tract Symptoms and the Role of Phosphodiesterase Type 5 Inhibitors

European Urology, 2009
Tobias S Kohler
exaly  

1-(2-Ethoxyethyl)-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors

Bioorganic and Medicinal Chemistry Letters, 2010
John K Walker
exaly  

The effect of phosphodiesterase-5 inhibitors on cerebral blood flow in humans: A systematic review

Journal of Cerebral Blood Flow and Metabolism, 2018
Mathilde Mh Pauls, Christina Kruuse, Atticus H Hainsworth   +2 more
exaly